Contract development and manufacturing organization (CDMO) Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients (APIs) following a €1.5 million grant from the Slovak Ministry of Education, Science, Research and Sport.
With over 70 years of opiate fully backward integrated production we can guarantee the highest quality and full control over the final product delivered to our customers.More Info
Slovakia-based contract development and manufacturing organisation (CDMO) Saneca Pharma has secured an agreement with Italian pharmaceutical company Menarini Group to deliver controlled release pellets for one of its products. As part of the five-year supply agreement, Saneca Pharma will be investing in its facility in Hlohovec, Slovakia, to increase the scale at which it can…
Come visit our team at stand 3P71, Hall 3 to find out what technical agility we can provide your company. And also how having us as your partner lets you use our responsive solutions to add real value to your portfolio more efficiently and with less risk. We also invite you to our “Come and Taste Slovakia” …
Do you want to attend?
+421 33 736 1111, email@example.com